<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="EUR" hierarchy="2" iati-activities:version="2.03" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>NL-KVK-27378529-PSS20CO01A</iati-identifier>
  <reporting-org ref="NL-KVK-27378529" secondary-reporter="0" type="10">
   <narrative xml:lang="EN">Netherlands Enterprise Agency</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">Breast cancer screening baseline assesment</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="EN">The Netherlands and Colombia have an agreement cooperation on to exchange knowledge and strengthen public health in the Life Sciences and Health Sector (LSH).  Colombia  has declared cancer as an illness of national priority. The challenge for the country is cantered in integral attention and quality, in particular to early detection/screening of breast cancer. The health system in Colombia is largely privatized. 89% of the insurance companies are private and 11% are mixed. 90%  or the oncological services are private. The Colombian system lacks standardized procedures and quality control for screening. Main problem is that health providers work under different standards for breast cancer screening. Treatment starts on late stages due to lack of prompt and quality diagnose, which increases the mortality rate (mainly of women). The assurance of quality control and screening at the same standard is an imperative need within the organizations that are part of the health system.The Netherlands has an added value to become a partner to support Colombia on this challenge. The Netherlands screening process is one of the most efficient in Europe and it is done by public health institutions in partnership with the Dutch Expert Centre for Screening (LRCB). LRBC is the unique organization who has integrated approach on quality assurance and quality control of breast cancer screening in the Netherlands and in Europe. The project enables the implementation of a site visit of one week by a multidisciplinary team of experts of the LRCB, who will elaborate a detailed baseline assessment of the actual breast cancer screening programme and will provide and advisory report with tailormade recommendations to the of the National Institute of Cancer of Colombia (INC).</narrative>
  </description>
  <participating-org ref="NL-KVK-27378529" role="1" type="10">
   <narrative xml:lang="EN">Netherlands Enterprise Agency</narrative>
  </participating-org>
  <participating-org ref="NL-KVK-27378529" role="2" type="10">
   <narrative xml:lang="EN">Netherlands Enterprise Agency</narrative>
  </participating-org>
  <participating-org role="4" type="10">
   <narrative xml:lang="EN">Netherlands embassy in Bogot&#xE1;, Colombia</narrative>
  </participating-org>
  <activity-status code="5"></activity-status>
  <activity-date iso-date="2020-10-25" type="1"></activity-date>
  <activity-date iso-date="2020-10-25" type="2"></activity-date>
  <activity-date iso-date="2021-04-24" type="3"></activity-date>
  <activity-date iso-date="2022-07-01" type="4"></activity-date>
  <recipient-country code="CO" percentage="100"></recipient-country>
  <location ref="CO">
   <point srsName="http://www.opengis.net/def/crs/EPSG/0/4326">
    <pos>16.7967129 96.1609916</pos>
   </point>
  </location>
  <sector code="12182" percentage="100" vocabulary="1"></sector>
  <sector code="8" percentage="1" vocabulary="7"></sector>
  <policy-marker code="4" significance="2" vocabulary="1"></policy-marker>
  <collaboration-type code="1"></collaboration-type>
  <default-flow-type code="30"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget status="2" type="1">
   <period-start iso-date="2020-08-19"></period-start>
   <period-end iso-date="2022-07-31"></period-end>
   <value currency="EUR" value-date="2020-08-19">20000</value>
  </budget>
  <budget status="2" type="1">
   <period-start iso-date="2022-07-01"></period-start>
   <period-end iso-date="2022-07-31"></period-end>
   <value currency="EUR" value-date="2022-07-01">-20000</value>
  </budget>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-08-19"></transaction-date>
   <value currency="EUR" value-date="2020-08-19">20000</value>
   <receiver-org type="90">
    <narrative xml:lang="EN"></narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-07-01"></transaction-date>
   <value currency="EUR" value-date="2022-07-01">-20000</value>
   <receiver-org type="90">
    <narrative xml:lang="EN"></narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="1"></transaction-type>
   <transaction-date iso-date="2020-08-19"></transaction-date>
   <value currency="EUR" value-date="2020-08-19">20000</value>
  </transaction>
  <transaction>
   <transaction-type code="1"></transaction-type>
   <transaction-date iso-date="2022-07-01"></transaction-date>
   <value currency="EUR" value-date="2022-07-01">-20000</value>
  </transaction>
  <related-activity ref="NL-KVK-27378529-26067_3" type="1"></related-activity>
 </iati-activity>
</iati-activities>
